Both classes of neurological diseases involved in the UNC13A and OTOF genes are reversible in clinical presentation [16,21], and the methylation levels of UNC13A and OTOF both had variability in the controlled trial of ω-3 fatty acids supplementations. This evidence concerns the gene UNC13A and nervous system disorder.